Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.90 $1.74 Friday, 10th May 2024 FGEN stock ended at $1.16. This is 4.92% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.04% from a day low at $1.12 to a day high of $1.21.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Sep 16, 2016 $20.00 $20.50 $19.81 $20.10 762 200
Sep 15, 2016 $19.12 $20.58 $18.95 $20.00 610 500
Sep 14, 2016 $18.66 $19.19 $18.55 $19.12 286 900
Sep 13, 2016 $18.75 $18.99 $18.19 $18.54 275 300
Sep 12, 2016 $18.22 $19.10 $18.20 $19.06 375 400
Sep 09, 2016 $18.92 $19.20 $18.28 $18.30 517 600
Sep 08, 2016 $19.29 $19.39 $18.79 $19.27 262 300
Sep 07, 2016 $19.03 $19.59 $18.91 $19.32 369 500
Sep 06, 2016 $18.06 $19.13 $17.94 $19.01 429 800
Sep 02, 2016 $17.42 $17.86 $17.19 $17.84 294 700
Sep 01, 2016 $17.32 $17.64 $17.04 $17.33 220 400
Aug 31, 2016 $17.72 $17.95 $17.27 $17.31 282 600
Aug 30, 2016 $17.62 $17.97 $17.46 $17.68 232 700
Aug 29, 2016 $17.99 $18.05 $17.44 $17.63 227 900
Aug 26, 2016 $17.60 $18.24 $17.47 $17.93 285 300
Aug 25, 2016 $18.08 $18.46 $17.13 $17.60 487 900
Aug 24, 2016 $19.41 $19.65 $17.75 $18.03 366 400
Aug 23, 2016 $19.23 $19.58 $18.86 $19.11 286 500
Aug 22, 2016 $18.59 $19.15 $18.43 $19.05 396 900
Aug 19, 2016 $18.36 $18.65 $18.12 $18.41 242 400
Aug 18, 2016 $18.33 $18.58 $18.16 $18.44 245 800
Aug 17, 2016 $18.36 $18.56 $18.19 $18.36 262 400
Aug 16, 2016 $19.13 $19.55 $18.38 $18.39 300 900
Aug 15, 2016 $19.24 $19.72 $19.13 $19.25 422 400
Aug 12, 2016 $18.38 $19.23 $18.26 $19.16 236 700
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT